Stryker Corp (SYK) Stock Price, Quote & News

Company Profile

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted v...

Industry: Medical Devices

Sector: Healthcare

Phone: (269) 385-2600

Fax: (269) 385-1062

Website: www.stryker.com

Address:

1941 Stryker Way, Portage, United States

RCFCIO0869 Aug. 29 at 1:45 AM

$SYK incredible undervalued on a fwd basis, like this one here, nice upward channel, if your going to get long now’s the time

0 · Reply

BioTechHealthX Aug. 28 at 10:26 AM

$SYK Stryker Corporation (NYSE: SYK) is turning robotic-assisted orthopedic surgery into a growing medical ecosystem. Could the Mako system make SYK a smart robotics stock? https://globalmarketbulletin.com/could-stryker-syk-become-a-major-winner-from-the-rise-of-robotic-surgery/

0 · Reply

richard74 Aug. 27 at 7:33 PM

$SYK adding on dip.

0 · Reply

dontbesoconfident Aug. 26 at 5:25 PM

$BSX it is truly embarrassing and almost irresponsible for the mgmt team that they didn't audit their security posture and implement the necessary measures after the $SYK cybersecurity incident of a few months back. This is an unnecessary, self inflicted setback as the stock tries to recover. Will take advantage of any future weakness.

0 · Reply

BioTechHealthX Aug. 26 at 2:47 PM

$AVAV $TER $ZBRA $ROK $SYK The robot revolution is moving from science fiction to Wall Street. Discover 10 robotics stocks positioned to benefit from humanoid robots, surgical automation, military drones, physical AI, and smart factories. https://globalmarketbulletin.com/10-best-robotics-stocks-to-buy-before-the-robot-revolution-takes-off/

0 · Reply

CapitalMonk Aug. 22 at 1:38 AM

$SYK Price: $329.45 (+0.53%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±0.25% RSI: 39.7 | Momentum: Strong Downside Volume: +0.8% vs avg Volatility: 2.47% Support: $317.62 | Resistance: $352.49 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

PaulineBoudreaux971 Aug. 20 at 7:30 AM

$NOW $NEM $GLW $SYK $PH ServiceNow benefits from enterprise software and AI adoption, Newmont benefits from gold prices, Corning benefits from optical and AI-networking demand, Stryker benefits from medical-device utilization, and Parker-Hannifin benefits from industrial and aerospace activity. I'm watching software bookings, gold prices, AI infrastructure, procedure volumes, and industrial demand.

0 · Reply

DonCorleone77 Aug. 18 at 9:38 PM

$SYK Stryker awarded $100M Defense Logistics Agency contract modification Stryker has been awarded a maximum $100M modification exercising the five-year option period of a five-year base contract with one five-year option period for patient monitoring and capital equipment. This is a fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract. The ordering period end date is Sept. 30, 2031. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is fiscal 2026 through 2031 defense working capital funds. The contracting activity is Defense Logistics Agency Troop Support.

0 · Reply

richard74 Aug. 17 at 10:40 PM

$SYK Today was a drag... Lets turn it around

0 · Reply

BioTechHealthX Aug. 15 at 5:22 PM

$SYK Stryker Corporation (NYSE: SYK) is building momentum around its Mako robotic surgery system. See why analysts like this medical device stock—and what could drive SYK next. https://biotechhealthx.com/biotech-news/is-stryker-syk-a-smart-stock-to-buy-for-long-term-growth/

0 · Reply

Market Cap	123.56B
Revenue (ttm)	25.12B
Net Income (ttm)	3.25B
EPS (ttm)	N/A
PE Ratio	23.63
Forward PE	21.94
Profit Margin	12.92%
Debt to Equity Ratio	0.62

Volume	2,227,700
Avg Vol	2,488,818
Day's Range	N/A - N/A
Shares Out	383.57M
Stochastic %K	41%
Beta	0.76
Analysts	Strong Sell
Price Target	$379.81